ESBATech

Switzerland
Schlieren, Zurich, Switzerland, 8952

Company profile

ESBATech company profile

Founded in 1998 as a spin out of the University of Zurich, ESBATech is committed to becoming one of the leading developers of fully human antibody fragments for therapeutic applications. The company applies its proprietary, fully human single-chain antibody frameworks to generate product candidates against targets of clinical relevance. ESBATech is focused on delivering high concentrations of its therapeutic antibody fragments to the targeted sites, in combination with extremely low systemic load, in order to achieve low risk of systemic drug reactions using topical and local delivery.

Business identity

Contact email
[email protected]
Phone number
+41447334990
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
1998-01-01, Year

Headquarters

Postal code
8952
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$72M
Last funding
Series B / $22M / 2008-08-07
Last equity funding
Series B / $22M
Investors
8
Lead investors
4
Founders
1
Articles
12
Exited on
2009-09-13

Founders and investors

Founders

Dominik Escher

Lead investors

Clarus VenturesHBM Healthcare InvestmentsLODH Immunology FundSV Health Investors

Investors

BioMedPartnersClarus VenturesNovartis Venture FundSV Health InvestorsVI Partners